Skip to main content
. 2018 Jun 12;8:8989. doi: 10.1038/s41598-018-27224-4

Figure 4.

Figure 4

ARB inhibits ZIKV in A549 cells. Cells were pretreated with various doses of ARB either 1 hour before ZIKV infection (RIGHT) or overnight (LEFT) prior to infection with ZIKV MR766 (MOI = 1). Virus was added to cells in the presence of drug, and two-hours later, viral inocula were removed. Medium containing fresh ARB at the respective doses was then added back to cells. Infection was monitored 48 h post infection by immune-staining cells with pan flavivirus anti-E protein antibody 4G2. The expression of protein antigen was quantified using anti-mouse HRP-TMB method by measuring absorbance at 650 nm. Viability was measured by CellTiter-Glo reagent (Promega). The solvent control (i.e. ethanol) was set at 100% for the infection and viability assessments and is reflected on the Y-axis. Data are means ± standard deviation of three replicates.